These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 18359598)

  • 21. 18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
    Ledezma CJ; Chen W; Sai V; Freitas B; Cloughesy T; Czernin J; Pope W
    Eur J Radiol; 2009 Aug; 71(2):242-8. PubMed ID: 18511228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraoperative dynamic susceptibility contrast weighted magnetic resonance imaging (iDSC-MRI) - Technical considerations and feasibility.
    Ulmer S; Helle M; Jansen O; Mehdorn HM; Nabavi A
    Neuroimage; 2009 Mar; 45(1):38-43. PubMed ID: 19100843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perfusion imaging of cerebral arteriovenous malformations: a study comparing quantitative continuous arterial spin labeling and dynamic contrast-enhanced magnetic resonance imaging at 3 T.
    Lüdemann L; Jedrzejewski G; Heidenreich J; Han ET; Bruhn H
    Magn Reson Imaging; 2011 Nov; 29(9):1157-64. PubMed ID: 21920687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative cerebral blood flow with bolus tracking perfusion MRI: measurements in porcine model and comparison with H(2)(15)O PET.
    Kellner E; Mix M; Reisert M; Förster K; Nguyen-Thanh T; Splitthoff DN; Gall P; Kiselev VG; Mader I
    Magn Reson Med; 2014 Dec; 72(6):1723-34. PubMed ID: 24375612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gadolinium-enhanced echo-planar T2-weighted MRI of tumors in the extracranial head and neck: feasibility study and preliminary results using a distributed-parameter tracer kinetic analysis.
    Bisdas S; Baghi M; Wagenblast J; Vogl TJ; Thng CH; Koh TS
    J Magn Reson Imaging; 2008 May; 27(5):963-9. PubMed ID: 18407543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. pASL versus DSC perfusion MRI in lateralizing temporal lobe epilepsy.
    Oner AY; Eryurt B; Ucar M; Capraz I; Kurt G; Bilir E; Tali T
    Acta Radiol; 2015 Apr; 56(4):477-81. PubMed ID: 24782571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive assessment of the functional neovasculature in 9L-glioma growing in rat brain by dynamic 1H magnetic resonance imaging of gadolinium uptake.
    van der Sanden BP; Rozijn TH; Rijken PF; Peters HP; Heerschap A; van der Kogel AJ; Bovée WM
    J Cereb Blood Flow Metab; 2000 May; 20(5):861-70. PubMed ID: 10826537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo biochemical 7.0 Tesla magnetic resonance: preliminary results of dGEMRIC, zonal T2, and T2* mapping of articular cartilage.
    Welsch GH; Mamisch TC; Hughes T; Zilkens C; Quirbach S; Scheffler K; Kraff O; Schweitzer ME; Szomolanyi P; Trattnig S
    Invest Radiol; 2008 Sep; 43(9):619-26. PubMed ID: 18708855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results.
    Bisdas S; Baghi M; Wagenblast J; Bisdas T; Thng CH; Mack MG; Koh TS; Ernemann U
    Clin Physiol Funct Imaging; 2009 Sep; 29(5):339-46. PubMed ID: 19473200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
    Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
    Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors.
    Weber MA; Zoubaa S; Schlieter M; Jüttler E; Huttner HB; Geletneky K; Ittrich C; Lichy MP; Kroll A; Debus J; Giesel FL; Hartmann M; Essig M
    Neurology; 2006 Jun; 66(12):1899-906. PubMed ID: 16801657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging.
    Provenzale JM; Wang GR; Brenner T; Petrella JR; Sorensen AG
    AJR Am J Roentgenol; 2002 Mar; 178(3):711-6. PubMed ID: 11856703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of renal perfusion: comparison of arterial spin labeling and dynamic contrast-enhanced MRI.
    Winter JD; St Lawrence KS; Cheng HL
    J Magn Reson Imaging; 2011 Sep; 34(3):608-15. PubMed ID: 21761490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla.
    Giesel FL; Mehndiratta A; Risse F; Rius M; Zechmann CM; von Tengg-Kobligk H; Gerigk L; Kauczor HU; Politi M; Essig M; Griffiths PD; Wilkinson ID
    Acta Radiol; 2009 Jun; 50(5):521-30. PubMed ID: 19337867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI.
    Lüdemann L; Grieger W; Wurm R; Wust P; Zimmer C
    Magn Reson Imaging; 2005 Oct; 23(8):833-41. PubMed ID: 16275421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative evaluation of 3-dimensional pseudocontinuous arterial spin labeling with dynamic contrast-enhanced perfusion magnetic resonance imaging in grading of human glioma.
    Roy B; Awasthi R; Bindal A; Sahoo P; Kumar R; Behari S; Ojha BK; Husain N; Pandey CM; Rathore RK; Gupta RK
    J Comput Assist Tomogr; 2013; 37(3):321-6. PubMed ID: 23673999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3D dynamic contrast-enhanced MRI of rectal carcinoma at 3T: correlation with microvascular density and vascular endothelial growth factor markers of tumor angiogenesis.
    Zhang XM; Yu D; Zhang HL; Dai Y; Bi D; Liu Z; Prince MR; Li C
    J Magn Reson Imaging; 2008 Jun; 27(6):1309-16. PubMed ID: 18504761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulse repetition time and contrast enhancement: simulation study of Gd-BOPTA and conventional contrast agent at different field strengths.
    Yrjänä SK; Vaara T; Karttunen A; Koivukangas J
    Invest Radiol; 2008 Apr; 43(4):267-75. PubMed ID: 18340251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of physiological and hemodynamic indices using T(1) dynamic contrast-enhanced MRI in intracranial mass lesions.
    Singh A; Haris M; Rathore D; Purwar A; Sarma M; Bayu G; Husain N; Rathore RK; Gupta RK
    J Magn Reson Imaging; 2007 Oct; 26(4):871-80. PubMed ID: 17896358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.